论文部分内容阅读
为了研究盆腔炎病人血浆、宫颈分泌物和子宫内膜组织中自介素6(IL-6)水平是否增加,以及与临床感染因素的关系等问题,由美国卫生机构参加,国家保健政策研究机构支助,对20例临床诊断盆腔炎的病人与20例无盆腔不适的妇科其他病人作对照,进行实验研究。通过酶联免疫实验方法测定病人血浆、宫颈分泌物和子宫内膜活检标本的IL-6水平,在临床和实验室参数基础上,根据病人体温、白细胞计数、细菌培养和盆腔检查情况,对盆腔炎病人严重
In order to investigate whether there is an increase in the level of interleukin-6 (IL-6) in the plasma, cervical secretions and endometrium in patients with pelvic inflammatory disease and the relationship with clinical infection factors, the United States Department of Health participated in the study. The National Institute of Health Policy Research Support for 20 cases of clinical diagnosis of pelvic inflammatory disease in patients with 20 cases of pelvic discomfort in gynecological control of other patients for experimental study. The levels of IL-6 in plasma, cervical secretions and endometrial biopsies of patients were determined by enzyme-linked immunosorbent assay. Based on the clinical and laboratory parameters, according to the patient’s body temperature, white blood cell count, bacterial culture and pelvic examination, pelvic Severe inflammation